Regeneron Pharmaceuticals, Inc. v. Samsung Bioepis, CO., LTD.,
Regeneron Pharmaceuticals, Inc. |
Samsung Bioepis, CO., LTD., and Samsung Bioepis Co., Ltd. |
WVN/1:23-CV-00094 |
November 21, 2023 |
Judicial Panel on Multidistrict Litigation |
Thomas S Kleeh |
Other |
Docket Report
This docket was last retrieved on January 12, 2024. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 4 ***TEXT ONLY ENTRY***MINUTE ORDER (re: pldg. ( 3 in MDL No. 3103) ) Plaintiff has moved to expedite consideration of its motion to transfer. The Panel considers all motions in due course and is not persuaded to depart from its long-standing practice. The motion for expedited consideration is DENIED. This matter will be set for the March 28, 2024 Hearing Session Order. Signed by Clerk of the Panel Tiffaney D. Pete on 1/12/2024. Associated Cases: MDL No. 3103, CAC/2:24-cv-00264, WVN/1:22-cv-00061, WVN/1:23-cv-00089, WVN/1:23-cv-00094, WVN/1:23-cv-00097, WVN/1:23-cv-00106 (DLD) Modified on 1/12/2024 (DLD). |
Filing 3 ***TEXT ONLY NOTICE***NOTICE OF FILING AND PUBLICATION OF BRIEFING SCHEDULE re: pldg. ( #1 in MDL No. 3103) BRIEFING SCHEDULE IS SET AS FOLLOWS:< br< Notices of Appearance due on or before 1/26/2024. Corporate Disclosure Statements due on or before 1/26/2024. Responses due on or before 2/2/2024. Reply, if any, due on or before 2/9/2024. In their briefs, the parties should address what steps they have taken to pursue alternatives to centralization (including, but not limited to, engaging in informal coordination of discovery and scheduling, and seeking Section 1404 transfer of one or more of the subject cases). #Appearance forms (JPML form 18) and #Corporate Disclosure forms can be downloaded from our website. Important: A Corporate Disclosure Form, if required, must be filed, even if one has previously been filed in this MDL.Please visit the #CM/ECF Filing Guidelines < Forms page of our website for additional information.Attorneys must be registered to file in the JPML. Please visit our website for #Registration Information.Signed by Clerk of the Panel Tiffaney D. Pete on 1/12/2024. Associated Cases: MDL No. 3103, CAC/2:24-cv-00264, WVN/1:22-cv-00061, WVN/1:23-cv-00089, WVN/1:23-cv-00094, WVN/1:23-cv-00097, WVN/1:23-cv-00106 (DLD) |
Filing 2 MDL Number 3103 Assigned -- MOTION FOR TRANSFER ACCEPTED FOR FILING re: pldg. ( #1 in Pending No. 5) Associated Cases: Pending No. 5, CAC/2:24-cv-00264, WVN/1:22-cv-00061, WVN/1:23-cv -00089, WVN/1:23-cv-00094, WVN/1:23-cv-00097, WVN/1:23-cv-00106 (DLD) |
Filing 1 MOTION TO EXPEDITE (re: pldg. #1 in MDL No. 3103) Filed by David Isaac Berl on behalf of Plaintiff Regeneron Pharmaceuticals, Inc. (Attachments: #1 Proof of Service) Associated Cases: Pending No. 5, CAC/2:24-cv-00264, WVN/1:22-cv-00061, WVN/1:23-cv-00089, WVN/1:23-cv-00094, WVN/1:23-cv-00097, WVN/1:23-cv-00106 (Berl, David) Modified on 1/12/2024 (DLD). REMOVED DUPLICATE PARTIES Modified on 1/16/2024 (DLD). REMOVED DUPLICATE ATTACHMENT NAME AND ADDED MDL LINK. |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.